Unknown

Dataset Information

A novel prognostic model: which group of esophageal squamous cell carcinoma patients could benefit from adjuvant chemotherapy.


ABSTRACT:

Background

This study aimed to establish a reliable model for predicting the overall survival (OS) of esophageal squamous cell carcinoma (ESCC) patients and identifying the potential beneficiaries of adjuvant chemotherapy after esophagectomy.

Methods

This retrospective study included 819 ESCC patients who underwent esophagectomy as the training cohort. We constructed a prognostic model named GTLN2. Both internal and external validation tests were performed. Potential beneficiaries were defined as ESCC patients who obtained a significantly longer OS after adjuvant chemotherapy. Propensity score matching (PSM) was utilized in the subgroup analysis to screen ESCC beneficiaries of adjuvant chemotherapy.

Results

We enrolled a total of 819 cT1b-3 patients in the training co

SUBMITTER: Zhou Z 

PROVIDER: S-EPMC8908144 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature